Literature DB >> 25801206

Epigenetic and transcriptional control of Foxp3+ regulatory T cells.

Jochen Huehn1, Marc Beyer2.   

Abstract

Regulatory T cells (Treg cells) present a unique T-cell lineage that plays a key role for the initiation and maintenance of immunological tolerance. Treg cells are characterized by the expression of the forkhead box transcription factor Foxp3, which acts as a lineage-specifying factor and determines the unique properties of these immunosuppressive cells. Work over the past few years has shown that well-defined and precisely controlled events on transcriptional and epigenetic level are required to ensure stable expression of Foxp3 in Treg cells. More recent work suggested that in addition to stable Foxp3 expression, epigenetic modifications of Treg-cell specific genes contribute to the unique phenotype of Treg cells by imprinting their transcriptional program and stabilizing the expression of molecules being essential for the suppressive properties of Treg cells. In this review, we will highlight how Foxp3 expression itself is epigenetically and transcriptionally controlled, how the Treg-cell specific epigenetic signature is achieved, how Foxp3 as transcription factor influences the gene expression programs in Treg cells and how unique properties of Treg-cell subsets are defined by other transcription factors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epigenetic regulation; Foxp3; Immunoregulation; Regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 25801206     DOI: 10.1016/j.smim.2015.02.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  47 in total

Review 1.  Epigenetic regulation of T helper cells and intestinal pathogenicity.

Authors:  Yuya Hagihara; Yusuke Yoshimatsu; Yohei Mikami; Yoshiaki Takada; Shinta Mizuno; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2019-03-19       Impact factor: 9.623

Review 2.  Novel Immunomodulatory Approaches for Porcine Islet Xenotransplantation.

Authors:  So-Hee Hong; Hyun-Je Kim; Seong-Jun Kang; Chung-Gyu Park
Journal:  Curr Diab Rep       Date:  2021-01-12       Impact factor: 4.810

3.  Thymus-derived Foxp3+ regulatory T cells upregulate RORγt expression under inflammatory conditions.

Authors:  Juhao Yang; Mangge Zou; Joern Pezoldt; Xuyu Zhou; Jochen Huehn
Journal:  J Mol Med (Berl)       Date:  2018-10-24       Impact factor: 4.599

Review 4.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

5.  Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.

Authors:  Braxton L Jamison; Tobias Neef; Andrew Goodspeed; Brenda Bradley; Rocky L Baker; Stephen D Miller; Kathryn Haskins
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

Review 6.  Targeting Treg signaling for the treatment of autoimmune diseases.

Authors:  Allyson Spence; Joanna E Klementowicz; Jeffrey A Bluestone; Qizhi Tang
Journal:  Curr Opin Immunol       Date:  2015-09-29       Impact factor: 7.486

Review 7.  Regulation of immunometabolism in adipose tissue.

Authors:  Manju Kumari; Joerg Heeren; Ludger Scheja
Journal:  Semin Immunopathol       Date:  2017-12-05       Impact factor: 9.623

Review 8.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 9.  Regulatory T Cells for More Targeted Immunosuppressive Therapies.

Authors:  Hazim Allos; Basmah S Al Dulaijan; John Choi; Jamil Azzi
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

Review 10.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.